{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:40Z","timestamp":1786979980456,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00330-019-06539-4","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T06:03:14Z","timestamp":1575439394000},"page":"1460-1469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Na Lae","family":"Eun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ju","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Mi","family":"Gweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-780X","authenticated-orcid":false,"given":"Ji Hyun","family":"Youk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"6539_CR1","doi-asserted-by":"crossref","unstructured":"Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30:96\u2013102","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469"},{"key":"6539_CR2","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","volume":"19","author":"M Kaufmann","year":"2012","unstructured":"Kaufmann M, von Minckwitz G, Mamounas EP et al (2012) Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol 19:1508\u20131516","journal-title":"Ann Surg Oncol"},{"key":"6539_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1200\/JCO.20.5.1304","volume":"20","author":"R Rouzier","year":"2002","unstructured":"Rouzier R, Extra JM, Klijanienko J et al (2002) Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20:1304\u20131310","journal-title":"J Clin Oncol"},{"key":"6539_CR4","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304\u20139311","journal-title":"J Clin Oncol"},{"key":"6539_CR5","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30:1796\u20131804","journal-title":"J Clin Oncol"},{"key":"6539_CR6","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657\u20133663","journal-title":"J Clin Oncol"},{"key":"6539_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455\u20131461","journal-title":"JAMA"},{"key":"6539_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14:609\u2013618","journal-title":"Lancet Oncol"},{"key":"6539_CR9","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","volume":"33","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Ballman KV, Hunt KK et al (2015) Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol 33:3386\u20133393","journal-title":"J Clin Oncol"},{"key":"6539_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","volume":"35","author":"A Peppe","year":"2017","unstructured":"Peppe A, Wilson R, Pope R, Downey K, Rusby J (2017) The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT). Breast 35:104\u2013108","journal-title":"Breast"},{"key":"6539_CR11","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","volume":"20","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Boughey JC, Jones KN, Shah SS, Glazebrook KN (2013) Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol 20:3199\u20133204","journal-title":"Ann Surg Oncol"},{"key":"6539_CR12","doi-asserted-by":"publisher","first-page":"20150143","DOI":"10.1259\/bjr.20150143","volume":"88","author":"S You","year":"2015","unstructured":"You S, Kang DK, Jung YS, An YS, Jeon GS, Kim TH (2015) Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 18F-FDG PET\/CT. Br J Radiol 88:20150143","journal-title":"Br J Radiol"},{"key":"6539_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejrad.2014.09.020","volume":"84","author":"RJ Schipper","year":"2015","unstructured":"Schipper RJ, Moossdorff M, Beets-Tan RGH, Smidt ML, Lobbes MBI (2015) Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review. Eur J Radiol 84:41\u201347","journal-title":"Eur J Radiol"},{"key":"6539_CR14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/0284185117690421","volume":"58","author":"SM Ha","year":"2017","unstructured":"Ha SM, Cha JH, Kim HH, Shin HJ, Chae EY, Choi WJ (2017) Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer. Acta Radiol 58:1198\u20131205","journal-title":"Acta Radiol"},{"key":"6539_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1634\/theoncologist.2016-0307","volume":"22","author":"RP Candelaria","year":"2017","unstructured":"Candelaria RP, Bassett RL, Symmans WF et al (2017) Performance of mid-treatment breast ultrasound and axillary ultrasound in predicting response to neoadjuvant chemotherapy by breast cancer subtype. Oncologist 22:394\u2013401","journal-title":"Oncologist"},{"key":"6539_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.crad.2015.04.019","volume":"70","author":"B Saffar","year":"2015","unstructured":"Saffar B, Bennett M, Metcalf C, Burrows S (2015) Retrospective preoperative assessment of the axillary lymph nodes in patients with breast cancer and literature review. Clin Radiol 70:954\u2013959","journal-title":"Clin Radiol"},{"key":"6539_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6:195\u2013197","journal-title":"J Oncol Pract"},{"key":"6539_CR18","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013","journal-title":"J Clin Oncol"},{"key":"6539_CR19","doi-asserted-by":"crossref","first-page":"36696","DOI":"10.18632\/oncotarget.13313","volume":"8","author":"BB Ye","year":"2017","unstructured":"Ye BB, Zhao HM, Yu Y, Ge J, Wang X, Cao XC (2017) Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients. Oncotarget 8:36696\u201336706","journal-title":"Oncotarget"},{"key":"6539_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4048\/jbc.2017.20.4.378","volume":"20","author":"HS Kim","year":"2017","unstructured":"Kim HS, Shin MS, Kim CJ et al (2017) Improved model for predicting axillary response to neoadjuvant chemotherapy in patients with clinically node-positive breast cancer. J Breast Cancer 20:378\u2013385","journal-title":"J Breast Cancer"},{"key":"6539_CR21","doi-asserted-by":"publisher","unstructured":"Kim R, Chang JM, Lee HB et al (2019) Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer. Radiology. https:\/\/doi.org\/10.1148\/radiol.2019190014:190014","DOI":"10.1148\/radiol.2019190014:190014"},{"key":"6539_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2214\/AJR.17.18295","volume":"210","author":"HT Le-Petross","year":"2018","unstructured":"Le-Petross HT, McCall LM, Hunt KK et al (2018) Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol 210:669\u2013676","journal-title":"AJR Am J Roentgenol"},{"key":"6539_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ultrasmedbio.2018.10.026","volume":"45","author":"WH Kim","year":"2019","unstructured":"Kim WH, Kim HJ, Park HY et al (2019) Axillary pathologic complete response to neoadjuvant chemotherapy in clinically node-positive breast cancer patients: a predictive model integrating the imaging characteristics of ultrasound restaging with known clinicopathologic characteristics. Ultrasound Med Biol 45:702\u2013709","journal-title":"Ultrasound Med Biol"},{"key":"6539_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1245\/s10434-017-5766-x","volume":"24","author":"TL Schwartz","year":"2017","unstructured":"Schwartz TL, Margenthaler JA (2017) Axillary ultrasound before neoadjuvant chemotherapy for breast cancer: don\u2019t discount the benefits yet! Ann Surg Oncol 24:618\u2013620","journal-title":"Ann Surg Oncol"},{"key":"6539_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","volume":"25","author":"O Kantor","year":"2018","unstructured":"Kantor O, Sipsy LM, Yao K, James TA (2018) A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 25:1304\u20131311","journal-title":"Ann Surg Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06539-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-019-06539-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06539-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T21:21:46Z","timestamp":1606944106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-019-06539-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["6539"],"URL":"https:\/\/doi.org\/10.1007\/s00330-019-06539-4","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Professor Ji Hyun Youk, MD, PhD, at Yonsei University College of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Retrospective\u2022 Diagnostic or prognostic study\u2022 Performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}